LVW Advisors LLC Purchases 5,224 Shares of Colgate-Palmolive Company $CL

Key Points

• LVW Advisors LLC increased its stake in Colgate-Palmolive Company by 103.1% during the second quarter, bringing their total holdings to 10,292 shares valued at approximately $936,000.
• Colgate-Palmolive recently reported a quarterly EPS of $0.92, exceeding analysts' expectations, with revenue of $5.11 billion for the quarter.
• The company announced a quarterly dividend of $0.52 per share, to be paid on November 14th, representing a 2.6% dividend yield.

LVW Advisors LLC boosted its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 103.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,292 shares of the company's stock after purchasing an additional 5,224 shares during the quarter. LVW Advisors LLC's holdings in Colgate-Palmolive were worth $936,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Westend Capital Management LLC raised its holdings in Colgate-Palmolive by 111.1% in the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 140 shares in the last quarter. Cornerstone Planning Group LLC raised its holdings in Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock worth $28,000 after purchasing an additional 287 shares in the last quarter. Saudi Central Bank bought a new position in Colgate-Palmolive in the first quarter worth $29,000. Ransom Advisory Ltd bought a new position in Colgate-Palmolive in the first quarter worth $33,000. Finally, Y.D. More Investments Ltd bought a new position in Colgate-Palmolive in the first quarter worth $37,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Trading Down 0.2%

Colgate-Palmolive stock opened at $79.57 on Friday. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a one year low of $78.76 and a one year high of $104.16. The stock has a market capitalization of $64.31 billion, a PE ratio of 22.35, a price-to-earnings-growth ratio of 4.14 and a beta of 0.35. The business's fifty day moving average is $84.19 and its 200 day moving average is $88.71.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.11 billion for the quarter, compared to analysts' expectations of $5.03 billion. During the same period last year, the firm posted $0.91 earnings per share. Colgate-Palmolive's revenue was up 1.0% compared to the same quarter last year. On average, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. Colgate-Palmolive's dividend payout ratio (DPR) is 58.43%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CL. JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Wells Fargo & Company cut their target price on Colgate-Palmolive from $83.00 to $80.00 and set an "underweight" rating on the stock in a research note on Thursday. UBS Group cut their target price on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research note on Thursday, July 17th. Citigroup cut their target price on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. Finally, Barclays increased their target price on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 15th. Seven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $97.73.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.